Comparison of the Effectiveness of Oral Lactase Enzyme and Lactose Free Formula
NCT ID: NCT06827405
Last Updated: 2025-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2022-06-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Management of Well Nourished Children With Persistent Diarrhea and Secondary Lactose Intolerance With Different Feeding Formulas.( Hospital-Originated Modified Feeding HOMF)
NCT07114796
Comparison Of Outcome Of Lactose Free Formula Milk With Yogurt In Children With Acute Diarrhea
NCT04796480
Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates
NCT07088302
Early Administration of Lactose-free Milk in Children Presenting With Acute Diarrhea
NCT01269892
Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country
NCT02246010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactase enzyme group
In this group, 5 drops of lactase enzyme (200 units lactase/drop)/ounce of milk, was added 5-30 minutes before feeding.
Lactase enzyme
Patients were given 5 drops of lactase enzyme (200 units lactase/drop)/ounce of milk, 5-30 minutes before feeding
Lactose-free formula feed group
In this group, lactose-free formula milk/diet was advised.
Lactose-free formula feed
Patients were advised lactose-free formula milk/diet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactase enzyme
Patients were given 5 drops of lactase enzyme (200 units lactase/drop)/ounce of milk, 5-30 minutes before feeding
Lactose-free formula feed
Patients were advised lactose-free formula milk/diet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 6-24 months
* Presented with persistent or severe persistent diarrhea due to secondary lactose intolerance
* Patients on formula or mixed feeding, or formula/cow/buffalo milk
Exclusion Criteria
* Hemodynamic instability (shock)
* Those on oral antibiotics or on excessive juices
* With conditions of malabsorptive states (celiac disease, protein losing enteropathy, or irritable bowel syndrome)
6 Months
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muhammad Aamir Latif
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Aamir Latif
Research Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatima Ghayas, FCPS
Role: PRINCIPAL_INVESTIGATOR
Hamdard University Hospital, Karachi
Heena Ghayas, FCPS
Role: STUDY_DIRECTOR
Ziauddin University Karachi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziauddin University Hospital, Kemari
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZUHKARACHI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.